School of Pharmacy, Queen's University Belfast, Belfast, UK.
Immunocore Ltd., Milton Park, Abingdon, UK.
Expert Rev Med Devices. 2022 Jul;19(7):533-538. doi: 10.1080/17434440.2022.2115355. Epub 2022 Aug 22.
Covid-19, alongside previous pandemics, has highlighted the need for the continued development of technologies that are at our disposal. Emerging technologies are those that show true promise in achieving such a goal and have begun to form sturdy independent research areas. Technological advances in healthcare must continually develop to ensure that the world is prepared for any future diseases that may ensue. As such, a strategic review into 43 manuscripts since 2019 has been conducted to determine the prominence of emerging technologies since the beginning of the Covid-19 pandemic.
Relating to their use in a pandemic state, additive manufacturing (AM), biofabrication, microfluidics, biomedical microelectromechanical systems (BioMEMS), and artificial intelligence (AI) are described. Applications over the past 2-3 years, as well as future developments, are considered throughout.
All the technologies mentioned in this review are sure to develop further, having shown their importance and value during the covid-19 pandemic. As research continues within the area, their efficacy will increase to the point where it likely will become gold standard for pandemic control. Combining certain technologies mentioned has also proved to have had great success in improving the final results obtained.
新冠疫情与以往的大流行病一起，凸显了继续开发我们现有的技术的必要性。新兴技术是那些在实现这一目标方面具有真正前景的技术，并已开始形成稳固的独立研究领域。医疗保健领域的技术进步必须不断发展，以确保世界为未来可能出现的任何疾病做好准备。因此，对 2019 年以来的 43 篇论文进行了战略审查，以确定自新冠疫情开始以来新兴技术的重要性。
本文描述了在大流行状态下的应用，包括增材制造（AM）、生物制造、微流控、生物医学微机电系统（BioMEMS）和人工智能（AI）。考虑了过去 2-3 年的应用以及未来的发展。
本综述中提到的所有技术肯定会进一步发展，因为它们在新冠疫情期间显示了重要性和价值。随着该领域的研究继续进行，它们的功效将提高到可能成为大流行控制的黄金标准的程度。某些提到的技术的结合也已被证明在提高最终获得的结果方面取得了巨大成功。
